Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells

Carcinogenesis

Volumn 30, Issue 9, 2009, Pages 1475-1486

  Chiu, Sou Tyau ^a,b,c   Chang, King Jen ^d   Ting, Chen Hung ^b   Shen, Hsi Che ^c   Li, Hung ^b   Hsieh, Fon Jou ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c Taipei County Hospital   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM ION; EPHRIN RECEPTOR B3; FIBRONECTIN; PLAKOGLOBIN; PROTEIN ZO1; UVOMORULIN; WNT PROTEIN; CRK LIKE PROTEIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CELL CONTACT; CELL JUNCTION; CELL MIGRATION; CELL POLARITY; COLON CANCER; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOSS; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELL STRAIN HT29; COLON TUMOR; HUMAN; MALE; MESODERM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL COMMUNICATION; CELL POLARITY; COLONIC NEOPLASMS; EPITHELIAL CELLS; HT29 CELLS; HUMANS; MALE; MESODERM; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; RECEPTOR, EPHB3; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS; WNT PROTEINS;

EID: 70249128037     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp133     Document Type: Article

References (53)

1. Chiu,S.T. et al. (2005) Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 14, 437-443.
2. Pasquale,E.B. (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell, 133, 38-52.
3. Arvanitis,D. et al. (2008) Eph/ephrin signaling: Networks. Genes Dev., 22, 416-429.
4. Batlle,E. et al. (2002) β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell, 111, 251-263.
5. Holmberg,J. et al. (2006) EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell, 125, 1151-1163.
6. Batlle,E. et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature, 435, 1126-1130.
7. Cortina,C. et al. (2007) EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat. Genet., 39, 1376-1383.
8. Hay,E.D. (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn., 233 706-720.
9. Thiery,J.P. et al. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol., 7, 131-142.
10. Lee,J.M. et al. (2006) The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J. Cell Biol., 172, 973-981.
11. Gavert,N. et al. (2008) Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med., 14, 199-209.
12. Barrios,A. et al. (2003) Eph/Ephrin signaling regulates the mesenchymalto-epithelial transition of the paraxial mesoderm during somite morphogenesis. Curr. Biol., 13, 1571-1582.
13. Noren,N.K. et al. (2006) The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat. Cell Biol., 8, 815-825.
14. Noren,N.K. et al. (2007) Paradoxes of the EphB4 receptor in cancer. Cancer Res., 67, 3994-3997.
15. Marquardt,T. et al. (2005) Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell, 121, 127-139.
16. Konstantinova,I. et al. (2007) EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell, 129, 359-370.
17. Tang,X.X. et al. (1999) Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin. Cancer Res., 5, 455-460.
18. Liu,W. et al. (2002) Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer, 94, 934-939.
19. Jubb,A.M. et al. (2005) EphB2 is a prognostic factor in colorectal cancer. Clin. Cancer Res., 11, 5181-5187.
20. Guo,D.L. et al. (2006) Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis, 27, 454-464.
21. Davalos,V. et al. (2006) EPHB4 and survival of colorectal cancer patients. Cancer Res., 66, 8943-8948.
22. Alazzouzi,H. et al. (2005) Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer Res., 65, 10170-10173.
23. Zelinski,D.P. et al. (2001) EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res., 61, 2301-2306.
24. Gale,N.W. et al. (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol., 230, 151-160.
25. Surawska,H. et al. (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev., 15, 419-433.
26. Carles-Kinch,K. et al. (2002) Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res., 62, 2840-2847.
27. Chen,J. et al. (2008) Eph receptors and Ephrins in cancer: Common themes and controversies. Cancer Res., 68, 10031-10033.
28. Reya,T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
29. Ellenbroek,S.I. et al. (2008) Rho GTPases: Functions and association with cancer. Clin. Exp. Metastasis, 24, 657-672.
30. Iden,S. et al. (2008) Crosstalk between small GTPases and polarity proteins in cell polarization. Nat. Rev. Mol. Cell Biol., 9, 846-859.
31. Fukata,M. et al. (2001) Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat. Rev. Mol. Cell Biol., 2, 887-897.
32. Lamorte,L. et al. (2002) Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. Mol. Biol. Cell, 13, 1449-1461.
33. Miao,H. et al. (2005) Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. J. Biol. Chem., 280, 923-932.
34. Ridley,A.J. (2001) Rho GTPases and cell migration. J. Cell Sci., 114, 2713-2722. 2722.
35. Dohn,M. et al. (2001) Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene, 20, 6503-6515.
36. Mann,B. et al. (1999) Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl Acad. Sci. USA, 96, 1603-1608.
37. Linghu,H. et al. (2006) Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell lineMCAS. Oncogene, 25, 3547-3556.
38. Takino,T. et al. (2003) CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res., 63, 2335-2337.
39. Rodrigues,S.P. et al. (2005) CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol. Cancer Res., 3, 183-194.
40. Mayer,B.J. et al. (1998) A novel viral oncogene with structural similarity to phospholipase C. Nature, 332, 272-275.
41. Perl,A.K. et al. (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392, 190-193.
42. Guarino,M. et al. (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology, 39, 305-318.
43. van de Wetering,M. et al. (2002) The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250.
44. Fuchs,S.Y. et al. (2005) Oncogenic β-catenin signaling networks in colorectal cancer. Cell Cycle, 4, 1522-1539.
45. Clevers,H. (2006) Wnt/β-catenin signaling in development and disease. Cell, 127, 469-480.
46. Wong,S.C. et al. (2004) Prognostic and diagnostic significance of β-catenin nuclear immunostaining in colorectal cancer. Clin. Cancer Res., 10, 1401-1408.
47. Mariadason,J.M. et al. (2001) Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res., 61, 3465-3471.
48. Naishiro,Y. et al. (2001) Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res., 61, 2751-2758.
49. Orsulic,S. et al. (1999) E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation. J. Cell Sci., 112, 1237-1245.
50. Fagotto,F. et al. (1996) Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus. J. Cell Biol., 132, 1105-1114.
51. Zhurinsky,J. et al. (2000) Plakoglobin and β-catenin: Protein interactions, regulation and biological roles. J. Cell Sci., 113, 3127-3139.
52. Simcha,I. et al. (1998) Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol., 141, 1433-1448.
53. Kofron,M. et al. (2002) Plakoglobin is required for maintenance of the cortical actin skeleton in early Xenopus embryos and for cdc42-mediated wound healing. J. Cell Biol., 158, 695-708.